Page last updated: 2024-09-02

fingolimod hydrochloride and Bladder Cancer

fingolimod hydrochloride has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, H; Horie, S; Katsuoka, Y; Muto, S; Otsuki, Y; Takahara, S1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Bladder Cancer

ArticleYear
Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
    The Journal of urology, 2003, Volume: 169, Issue:6

    Topics: Animals; Apoptosis; Blotting, Western; Cell Division; Cell Line; Cell Survival; DNA Fragmentation; DNA, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Fibroblasts; Fingolimod Hydrochloride; Hepatocyte Growth Factor; Humans; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; Phosphorylation; Propylene Glycols; Sphingosine; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2003